Tempest Therapeutics logo

Tempest Therapeutics Share Price (NASDAQ: TPST)

$9.98

0.13

(1.32%)

Live

Last updated on

Check the interactive Tempest Therapeutics Stock chart to analyse performance

Tempest Therapeutics stock performance

as on August 30, 2025 at 12:17 am IST

  • Today's Low:$9.85
    Today's High:$9.98

    Day's Volatility :1.3%

  • 52 Weeks Low:$5.35
    52 Weeks High:$20.67

    52 Weeks Volatility :74.12%

Tempest Therapeutics Stock Returns

PeriodTempest Therapeutics IncIndex (Russel 2000)
3 Months
65.55%
0.0%
6 Months
-6.39%
0.0%
1 Year
-43.87%
0.0%
3 Years
-64.92%
-6.1%

Tempest Therapeutics Inc Key Stats

Check Tempest Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$9.85
Open
$10.64
Today's High
$9.89
Today's Low
$9.82
Market Capitalization
$47.8M
Today's Volume
$127.5K
52 Week High
$20.67
52 Week Low
$5.3495
Revenue TTM
$0.0
EBITDA
$-43.1M
Earnings Per Share (EPS)
$-14.52
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-322.57%

Stock Returns calculator for Tempest Therapeutics Stock including INR - Dollar returns

The Tempest Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tempest Therapeutics investment value today

Current value as on today

₹62,043

Returns

₹37,957

(-37.96%)

Returns from Tempest Therapeutics Stock

₹43,134 (-43.13%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Tempest Therapeutics Stock

-73%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Tempest Therapeutics Stock from India on INDmoney has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Tempest Therapeutics Inc

  • Name

    Holdings %

  • Versant Venture Management LLC

    6.08%

  • TANG CAPITAL MANAGEMENT LLC

    3.13%

  • Vanguard Group Inc

    3.03%

  • Atlantic Trust Group, LLC

    0.01%

Analyst Recommendation on Tempest Therapeutics Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Tempest Therapeutics(by analysts ranked 0 to 5 stars)

Tempest Therapeutics Share Price Target

What analysts predicted

Downside of 9.82%

Target:

$9.00

Current:

$9.98

Tempest Therapeutics share price target is $9.00, a slight Downside of 9.82% compared to current price of $9.98 as per analysts' prediction.

Tempest Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, TPST stock has moved up by 35.7%
  • TPST vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 101.4%
  • TPST vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 180.9%

Tempest Therapeutics Technicals Summary

Sell

Neutral

Buy

Tempest Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Tempest Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tempest Therapeutics Inc logo
30.64%
-6.39%
-43.87%
-64.92%
-94.33%
Regeneron Pharmaceuticals, Inc. logo
3.77%
-17.64%
-51.18%
-2.19%
-7.17%
Beone Medicines Ltd logo
-0.02%
10.33%
51.07%
81.16%
24.14%
Vertex Pharmaceuticals Incorporated logo
-16.39%
-18.24%
-20.49%
39.42%
40.54%
Alnylam Pharmaceuticals, Inc. logo
33.05%
83.22%
57.52%
115.32%
240.85%

About Tempest Therapeutics Inc

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Organization
Tempest Therapeutics
Employees
21
CEO
Mr. Stephen R. Brady J.D., LLM
Industry
Miscellaneous

Key Management of Tempest Therapeutics Inc

NameTitle
Mr. Stephen R. Brady J.D., LLM
CEO, President & Director
Mr. Nicholas Maestas
CFO, Head of Corporate Strategy & Secretary
Dr. Samuel Whiting M.D., Ph.D.
Executive VP, Chief Medical Officer and Head of R&D
Ms. Lindsay Young
Head of Human Resources

Important FAQs about investing in TPST Stock from India :

What is Tempest Therapeutics share price today?

Tempest Therapeutics share price today is $9.98 as on . Tempest Therapeutics share today touched a day high of $9.98 and a low of $9.85.

What is the 52 week high and 52 week low for Tempest Therapeutics share?

Tempest Therapeutics share touched a 52 week high of $20.67 and a 52 week low of $5.35. Tempest Therapeutics stock price today i.e. is trending at $9.98, lower by 51.72% versus the 52 week high.

How to invest in Tempest Therapeutics Stock (TPST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tempest Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tempest Therapeutics Shares that will get you 0.1503 shares as per Tempest Therapeutics share price of $9.98 per share as on August 30, 2025 at 12:17 am IST.

What is the minimum amount required to buy Tempest Therapeutics Stock (TPST) from India?

Indian investors can start investing in Tempest Therapeutics (TPST) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Tempest Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Tempest Therapeutics share’s latest price of $9.98 as on August 30, 2025 at 12:17 am IST, you will get 1.0020 shares of Tempest Therapeutics. Learn more about fractional shares .

What are the returns that Tempest Therapeutics has given to Indian investors in the last 5 years?

Tempest Therapeutics stock has given -94.33% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?